Novartis Earnings Estimate
| NVS Stock | USD 109.06 0.05 0.05% |
Novartis Revenue Breakdown by Earning Segment
By analyzing Novartis' earnings estimates, investors can diagnose different trends across Novartis' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit Margin is likely to gain to 0.78 in 2025, whereas Gross Profit is likely to drop slightly above 32.6 B in 2025.
Novartis |
Novartis Earnings Estimation Breakdown
The calculation of Novartis' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Novartis is estimated to be 2.0567 with the future projection ranging from a low of 1.9633 to a high of 2.15. Please be aware that this consensus of annual earnings estimates for Novartis AG ADR is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
1.96 Lowest | Expected EPS | 2.15 Highest |
Novartis Earnings Projection Consensus
Suppose the current estimates of Novartis' value are higher than the current market price of the Novartis stock. In this case, investors may conclude that Novartis is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Novartis' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 12 | 93.51% | 1.98 | 2.0567 | 5.87 |
Novartis Earnings History
Earnings estimate consensus by Novartis AG ADR analysts from Wall Street is used by the market to judge Novartis' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Novartis' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Novartis Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novartis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novartis Earnings per Share Projection vs Actual
Actual Earning per Share of Novartis refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Novartis AG ADR predict the company's earnings will be in the future. The higher the earnings per share of Novartis, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Novartis Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Novartis, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Novartis should always be considered in relation to other companies to make a more educated investment decision.Novartis Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Novartis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-01-31 | 2024-12-31 | 1.7768 | 1.98 | 0.2032 | 11 | ||
2024-10-29 | 2024-09-30 | 1.96 | 2.06 | 0.1 | 5 | ||
2024-07-18 | 2024-06-30 | 1.89 | 1.97 | 0.08 | 4 | ||
2024-04-23 | 2024-03-31 | 1.69 | 1.8 | 0.11 | 6 | ||
2024-01-31 | 2023-12-31 | 1.69 | 1.53 | -0.16 | 9 | ||
2023-10-24 | 2023-09-30 | 1.7 | 1.83 | 0.13 | 7 | ||
2023-07-19 | 2023-06-30 | 1.68 | 1.83 | 0.15 | 8 | ||
2023-04-25 | 2023-03-31 | 1.55 | 1.71 | 0.16 | 10 | ||
2023-02-01 | 2022-12-31 | 1.44 | 1.52 | 0.08 | 5 | ||
2022-10-25 | 2022-09-30 | 1.55 | 1.58 | 0.03 | 1 | ||
2022-07-19 | 2022-06-30 | 1.5 | 1.56 | 0.06 | 4 | ||
2022-04-26 | 2022-03-31 | 1.44 | 1.46 | 0.02 | 1 | ||
2022-02-02 | 2021-12-31 | 1.41 | 1.4 | -0.01 | 0 | ||
2021-10-26 | 2021-09-30 | 1.65 | 1.71 | 0.06 | 3 | ||
2021-07-21 | 2021-06-30 | 1.53 | 1.66 | 0.13 | 8 | ||
2021-04-27 | 2021-03-31 | 1.59 | 1.52 | -0.07 | 4 | ||
2021-01-26 | 2020-12-31 | 1.36 | 1.34 | -0.02 | 1 | ||
2020-10-27 | 2020-09-30 | 1.45 | 1.52 | 0.07 | 4 | ||
2020-07-21 | 2020-06-30 | 1.31 | 1.36 | 0.05 | 3 | ||
2020-04-28 | 2020-03-31 | 1.37 | 1.56 | 0.19 | 13 | ||
2020-01-29 | 2019-12-31 | 1.29 | 1.32 | 0.03 | 2 | ||
2019-10-22 | 2019-09-30 | 1.36 | 1.41 | 0.05 | 3 | ||
2019-07-18 | 2019-06-30 | 1.22 | 1.34 | 0.12 | 9 | ||
2019-04-24 | 2019-03-31 | 1.16 | 1.21 | 0.05 | 4 | ||
2019-01-30 | 2018-12-31 | 1.28 | 1.25 | -0.03 | 2 | ||
2018-10-18 | 2018-09-30 | 1.3 | 1.32 | 0.02 | 1 | ||
2018-07-18 | 2018-06-30 | 1.27 | 1.29 | 0.02 | 1 | ||
2018-04-19 | 2018-03-31 | 1.28 | 1.28 | 0.0 | 0 | ||
2018-01-24 | 2017-12-31 | 1.19 | 1.21 | 0.02 | 1 | ||
2017-10-24 | 2017-09-30 | 1.25 | 1.29 | 0.04 | 3 | ||
2017-07-18 | 2017-06-30 | 1.19 | 1.21 | 0.02 | 1 | ||
2017-04-25 | 2017-03-31 | 1.11 | 1.13 | 0.02 | 1 | ||
2017-01-25 | 2016-12-31 | 1.11 | 1.11 | 0.0 | 0 | ||
2016-10-25 | 2016-09-30 | 1.19 | 1.23 | 0.04 | 3 | ||
2016-07-19 | 2016-06-30 | 1.18 | 1.23 | 0.05 | 4 | ||
2016-04-21 | 2016-03-31 | 1.18 | 1.16 | -0.02 | 1 | ||
2016-01-27 | 2015-12-31 | 1.18 | 1.09 | -0.09 | 7 | ||
2015-10-27 | 2015-09-30 | 1.31 | 1.27 | -0.04 | 3 | ||
2015-07-21 | 2015-06-30 | 1.24 | 1.25 | 0.01 | 0 | ||
2015-04-23 | 2015-03-31 | 1.1 | 1.29 | 0.19 | 17 | ||
2015-01-27 | 2014-12-31 | 1.21 | 1.21 | 0.0 | 0 | ||
2014-10-28 | 2014-09-30 | 1.29 | 1.37 | 0.08 | 6 | ||
2014-07-17 | 2014-06-30 | 1.4 | 1.34 | -0.06 | 4 | ||
2014-04-24 | 2014-03-31 | 1.33 | 1.28 | -0.05 | 3 | ||
2014-01-29 | 2013-12-31 | 1.26 | 1.19 | -0.07 | 5 | ||
2013-10-22 | 2013-09-30 | 1.31 | 1.25 | -0.06 | 4 | ||
2013-07-17 | 2013-06-30 | 1.29 | 1.3 | 0.01 | 0 | ||
2013-04-24 | 2013-03-31 | 1.28 | 1.32 | 0.04 | 3 | ||
2013-01-23 | 2012-12-31 | 1.19 | 1.27 | 0.08 | 6 | ||
2012-10-25 | 2012-09-30 | 1.36 | 1.34 | -0.02 | 1 | ||
2012-07-19 | 2012-06-30 | 1.29 | 1.38 | 0.09 | 6 | ||
2012-04-24 | 2012-03-31 | 1.32 | 1.27 | -0.05 | 3 | ||
2012-01-25 | 2011-12-31 | 1.2 | 1.23 | 0.03 | 2 | ||
2011-10-25 | 2011-09-30 | 1.51 | 1.45 | -0.06 | 3 | ||
2011-07-19 | 2011-06-30 | 1.4 | 1.48 | 0.08 | 5 | ||
2011-04-19 | 2011-03-31 | 1.31 | 1.41 | 0.1 | 7 | ||
2011-01-27 | 2010-12-31 | 1.25 | 1.14 | -0.11 | 8 | ||
2010-10-21 | 2010-09-30 | 1.2 | 1.27 | 0.07 | 5 | ||
2010-07-15 | 2010-06-30 | 1.13 | 1.2 | 0.07 | 6 | ||
2010-04-20 | 2010-03-31 | 1.23 | 1.44 | 0.21 | 17 | ||
2010-01-26 | 2009-12-31 | 1.1 | 1.01 | -0.09 | 8 | ||
2009-10-22 | 2009-09-30 | 0.95 | 0.92 | -0.03 | 3 | ||
2009-07-16 | 2009-06-30 | 0.85 | 0.89 | 0.04 | 4 | ||
2009-04-23 | 2009-03-31 | 0.87 | 0.87 | 0.0 | 0 | ||
2009-01-28 | 2008-12-31 | 0.79 | 0.66 | -0.13 | 16 | ||
2008-10-20 | 2008-09-30 | 0.95 | 0.92 | -0.03 | 3 | ||
2008-07-17 | 2008-06-30 | 0.93 | 0.98 | 0.05 | 5 | ||
2008-04-21 | 2008-03-31 | 0.89 | 1.02 | 0.13 | 14 | ||
2008-01-17 | 2007-12-31 | 0.73 | 0.4 | -0.33 | 45 | ||
2007-10-18 | 2007-09-30 | 0.76 | 0.68 | -0.08 | 10 | ||
2007-07-17 | 2007-06-30 | 0.78 | 0.83 | 0.05 | 6 | ||
2007-04-23 | 2007-03-31 | 0.84 | 0.92 | 0.08 | 9 | ||
2007-01-18 | 2006-12-31 | 0.78 | 0.7 | -0.08 | 10 | ||
2006-10-19 | 2006-09-30 | 0.76 | 0.79 | 0.03 | 3 | ||
2006-07-17 | 2006-06-30 | 0.79 | 0.73 | -0.06 | 7 | ||
2006-04-24 | 2006-03-31 | 0.71 | 0.83 | 0.12 | 16 | ||
2006-01-19 | 2005-12-31 | 0.71 | 0.58 | -0.13 | 18 | ||
2005-10-18 | 2005-09-30 | 0.72 | 0.71 | -0.01 | 1 | ||
2005-07-14 | 2005-06-30 | 0.66 | 0.7 | 0.04 | 6 | ||
2005-01-20 | 2004-12-31 | 0.6 | 0.56 | -0.04 | 6 | ||
2004-10-21 | 2004-09-30 | 0.58 | 0.63 | 0.05 | 8 | ||
2004-07-20 | 2004-06-30 | 0.59 | 0.63 | 0.04 | 6 | ||
2004-04-22 | 2004-03-31 | 0.53 | 0.52 | -0.01 | 1 | ||
2004-01-22 | 2003-12-31 | 0.53 | 0.55 | 0.02 | 3 | ||
2003-10-20 | 2003-09-30 | 0.52 | 0.52 | 0.0 | 0 | ||
2003-07-21 | 2003-06-30 | 0.51 | 0.52 | 0.01 | 1 | ||
2003-04-15 | 2003-03-31 | 0.46 | 0.43 | -0.03 | 6 | ||
2003-01-23 | 2002-12-31 | 0.42 | 0.45 | 0.03 | 7 | ||
2002-10-17 | 2002-09-30 | 0.44 | 0.4713 | 0.0313 | 7 | ||
1998-03-17 | 1997-12-31 | 0.56 | 0.51 | -0.05 | 8 | ||
1997-09-02 | 1997-06-30 | 0.79 | 0.79 | 0.0 | 0 | ||
1997-04-22 | 1997-03-31 | 0.45 | 0.52 | 0.07 | 15 |
About Novartis Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Novartis earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Novartis estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Novartis fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | 57.1 B | 58 B | |
| Earnings Yield | 0.06 | 0.05 | |
| Price Earnings Ratio | 16.46 | 14.26 | |
| Price Earnings To Growth Ratio | (0.99) | (0.94) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.